SCHEMBL30977435

SCHEMBL30977435

c1ccn2nc(C3CCOC3)cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.39
ALDH1A1 P00352 3/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAP4K4 O95819 1/20 0.36
ABL1 P00519 1/20 0.36
MAPK8 P45983 1/20 0.36
CSNK1A1 P48729 1/20 0.36
CDK7 P50613 1/20 0.36
TYRO3 Q06418 1/20 0.36
LRRK2 Q5S007 1/20 0.36
AURKB Q96GD4 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36
PIM2 Q9P1W9 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
LMNA P02545 1/20 0.36
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3194072 0.82 HDAC4 (0.44) HDAC4ALDH1A1L3MBTL1MAP4K4ABL1
SCHEMBL3957685 0.79 NPC1 (0.44) HDAC4ALDH1A1L3MBTL1MAP4K4ABL1
SCHEMBL31024085 0.79 NPC1 (0.47) HDAC4ALDH1A1L3MBTL1MAP4K4ABL1
SCHEMBL31024054 0.72 KDM4E (0.43) HDAC4MAP4K4ABL1MAPK8CSNK1A1
SCHEMBL2144027 0.72 JAK2 (0.38) CYP3A4IDO1TDO2PDE10A
SCHEMBL25731567 0.68 DDB1 (0.41) LRRK2NPC1RAB9ASMN1; SMN2PDE1A
SCHEMBL29548842 0.68 MAP4K4 (0.35) HDAC4MAP4K4ABL1MAPK8CSNK1A1
SCHEMBL32667194 0.67 OPRM1 (0.38) ALDH1A1NPC1RAB9ALMNATP53
SCHEMBL28118056 0.67 OPRM1 (0.38) ALDH1A1NPC1RAB9ALMNATP53
SCHEMBL11655744 0.66 PRKDC (0.47) ALDH1A1L3MBTL1MAP4K4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619402-A1 GPR17 MODULATORS AND USES THEREOF Myrobalan Therapeutics, Inc. (US) 2025-09-24 EP disclosed
CN-119613397-A N-heteroaromatic ring-3-sulfonamide compounds and use thereof for preparing GPR17 receptor inhibitors 迈巴制药(南京)有限公司 2025-03-14 CN disclosed
CN-118475580-A Platelet-derived growth factor receptor (PDGFR) alpha inhibitors and uses thereof 普罗根托斯治疗公司 2024-08-09 CN disclosed
WO-2024104462-A1 GPR17 MODULATORS AND USES THEREOF MYROBALAN THERAPEUTICS NANJING CO. LTD (CN) 2024-05-23 WO disclosed